[go: up one dir, main page]

WO2018222167A3 - Use of a herbal formulation containing linseed oil in the treatment of cardiovascular system diseases - Google Patents

Use of a herbal formulation containing linseed oil in the treatment of cardiovascular system diseases Download PDF

Info

Publication number
WO2018222167A3
WO2018222167A3 PCT/TR2018/050093 TR2018050093W WO2018222167A3 WO 2018222167 A3 WO2018222167 A3 WO 2018222167A3 TR 2018050093 W TR2018050093 W TR 2018050093W WO 2018222167 A3 WO2018222167 A3 WO 2018222167A3
Authority
WO
WIPO (PCT)
Prior art keywords
linseed oil
treatment
cardiovascular system
formulation containing
system diseases
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/TR2018/050093
Other languages
French (fr)
Other versions
WO2018222167A9 (en
WO2018222167A2 (en
Inventor
Mevlüt Büyükhelvacigi̇l
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Helvacizade Gida Ilac Kimya Sanayi Ve Ticaret AS
Original Assignee
Helvacizade Gida Ilac Kimya Sanayi Ve Ticaret AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Helvacizade Gida Ilac Kimya Sanayi Ve Ticaret AS filed Critical Helvacizade Gida Ilac Kimya Sanayi Ve Ticaret AS
Publication of WO2018222167A2 publication Critical patent/WO2018222167A2/en
Publication of WO2018222167A3 publication Critical patent/WO2018222167A3/en
Publication of WO2018222167A9 publication Critical patent/WO2018222167A9/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/55—Linaceae (Flax family), e.g. Linum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Botany (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

In pharmaceutical industry; the invention relates to use of an herbal formulation containing linseed oil being rich in alpfa-linolenic acid (ALA) that is an herbal Omega 3 fatty acid in the treatment of cardiovascular system diseases. Said herbal formulation comprises linseed oil, dl α-tocopherol, dl α-tocopheril acetate, glycerine, purified water and gelatine maintaining the integrity and formation of the content.
PCT/TR2018/050093 2017-03-10 2018-03-09 Use of a herbal formulation containing linseed oil in the treatment of cardiovascular system diseases Ceased WO2018222167A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
TR2017/03736 2017-03-10
TR2017/03736A TR201703736A2 (en) 2017-03-10 2017-03-10 THE USE OF A VEGETABLE FORMULATION CONTAINING LINEN SEED OIL IN THE TREATMENT OF HEART Vascular SYSTEM DISEASES

Publications (3)

Publication Number Publication Date
WO2018222167A2 WO2018222167A2 (en) 2018-12-06
WO2018222167A3 true WO2018222167A3 (en) 2019-01-17
WO2018222167A9 WO2018222167A9 (en) 2019-04-11

Family

ID=64456358

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/TR2018/050093 Ceased WO2018222167A2 (en) 2017-03-10 2018-03-09 Use of a herbal formulation containing linseed oil in the treatment of cardiovascular system diseases

Country Status (2)

Country Link
TR (1) TR201703736A2 (en)
WO (1) WO2018222167A2 (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101103966A (en) * 2006-07-14 2008-01-16 上海展望科技有限公司 Omega-3 falty acid-garlic oil capsule and manufacturing method thereof
CN101919457A (en) * 2010-09-01 2010-12-22 吴桂荣 Blended linseed oil and applications
CN104288345A (en) * 2013-07-15 2015-01-21 湘北威尔曼制药股份有限公司 A traditional Chinese medicine composition assisting blood lipid reduction and a preparing method thereof

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101103966A (en) * 2006-07-14 2008-01-16 上海展望科技有限公司 Omega-3 falty acid-garlic oil capsule and manufacturing method thereof
CN101919457A (en) * 2010-09-01 2010-12-22 吴桂荣 Blended linseed oil and applications
CN104288345A (en) * 2013-07-15 2015-01-21 湘北威尔曼制药股份有限公司 A traditional Chinese medicine composition assisting blood lipid reduction and a preparing method thereof

Also Published As

Publication number Publication date
WO2018222167A9 (en) 2019-04-11
WO2018222167A2 (en) 2018-12-06
TR201703736A2 (en) 2017-07-21

Similar Documents

Publication Publication Date Title
WO2013170006A3 (en) Oils with anti-inflammatory activity containing natural specialized proresolving mediators and their precursors
MX384370B (en) LIPID THAT INCLUDES LONG-CHAIN POLYUNSATURATED FATTY ACIDS.
MX384154B (en) PROCESS FOR INCREASING THE STABILITY OF A COMPOSITION COMPRISING POLYUNSATURATED OMEGA-3 FATTY ACIDS.
MX390089B (en) COMPOSITIONS OF REFINED OIL AND METHODS FOR ITS PREPARATION.
MY181997A (en) Preparation and composition of medium chain triglycerides containing substantial amount of lauric acid
WO2009008683A3 (en) Multi-layered vitamin complex tablet containing ubidecarenone
EA201791537A1 (en) PHARMACEUTICAL COMPOSITION ON THE BASIS OF NANOPARTICLES OF DOCETAXEL-ALBUMIN, METHOD FOR ITS PREPARATION AND ITS APPLICATION
MX391057B (en) PROCESS FOR INCREASING THE STABILITY OF A COMPOSITION COMPRISING POLYUNSATURATED OMEGA-6 FATTY ACIDS.
MX2017016320A (en) Nutritional compositions and methods for promoting cognitive development.
PH12017500269A1 (en) Composite formulation for oral administration comprising omega-3 fatty acid esters and statins
MX2018013728A (en) Method for producing celastrol and pentacyclic triterpene derivatives.
WO2017062523A3 (en) Oil compositions and methods of making
SG11201804550SA (en) Method for enriching protists with lipids rich in polyunsaturated fatty acids, more particularly of the omega 3 class, and implementation of same for the production of said lipids
MX2021009825A (en) NUTRITIONAL SUPPLEMENT.
MX2017010716A (en) Millicapsule formulations comprising polyunsaturated free fatty acids.
WO2018222167A3 (en) Use of a herbal formulation containing linseed oil in the treatment of cardiovascular system diseases
WO2018226191A3 (en) Use of a herbal formulation containing linseed oil in the treatment of mild gastrointestinal (gastrointestinal system) disorders
WO2018222166A3 (en) Use of an herbal formulation containing linseed oil in the treatment of regulating some blood lipid (fat) levels
WO2018226192A3 (en) Use of a herbal formulation containing linseed oil on those who cannot use fish oil, particularly on vegetarians as a herbal omega 3 (ala) source
WO2019004968A3 (en) Use of a vegetal formulation containing pomegranate seed oil as an immune system enhancer due to its antioxidant function
BR112017002475A2 (en) non therapeutic cosmetic compositions and method
TWI633896B (en) Artificial sebum film and manufacturing method thereof
EA201692398A1 (en) HOMOGENE COMPOSITION FOR ORAL ADMINISTRATION, CONTAINING OMEGA-3 POLYINSATURATED FATTY ACIDS AND RESVERATROL
WO2019004969A3 (en) Use of a vegetal formulation containing pomegranate seed oil as an assistive agent in reduction of blood lipids known as triglyceride
WO2017160694A3 (en) Compositions for providing vitamin d to the skin

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 18810355

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 18810355

Country of ref document: EP

Kind code of ref document: A2